Solamargine

N/A

Report date: 2024/01/25 09:17:33
NME

Base Information

Drug NameSolamargine
Drug Alias NameSolamargine gelSR-T100
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionApoptosis stimulantsP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsDepressive Disorder, MajorKeratosis, ActinicVulvar Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanJapan
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesG&E Herbal Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcG&E Herbal Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorKeratosis, ActinicVulvar Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A